Abstract

Objective: To demonstrate the prognostic value of the LODDS in the probability of survival at 5 years in resectable colorectal carcinoma
Material and Methods: Survival analysis of a consecutive series of 71 patients who underwent colectomy for adenocarcinoma of the colon and upper rectum - middle, in the Oncological Surgery Service of the High Complexity Hospital “Virgen de la Puerta” EsSalud de Trujillo - Peru during the years 2018-2019. The follow-up was carried out until 06/01/2020.
Results: The mean age of the total series was 66.7 ± 15.1 years (range: 32 - 92 years). The male sex (52.1%) predominated over the female (47.9%). The median time of illness was 7 months (range: 1.0 - 36 months). The 5-year actuarial survival rates in colorectal cancer patients were 94.1%, 93.2% and 80% for pN1, pN2 and pN3 respectively (p = 0.414). The 5-year actuarial survival rates in colorectal cancer patients were 100%, 97.6%, and 80.7% for LODDS 0, LODDS 1, and LODDS 2, respectively (p = 0.414).
Conclusion: The LODDS has a prognostic value in actuarial survival at 5 years in patients with colorectal carcinoma.

Keywords:LODDS; 5-year survival; Locorectal carcinoma